Sequella
About:
Sequella is a biopharmaceutical company developing products for the diagnosis and treatment of epedemic infectious diseases.
Website: http://www.sequella.com
Description:
Sequella is a clinical-stage biopharmaceutical company, develops products for the diagnosis and treatment of infectious diseases. The company focuses on commercializing treatment paradigms for diseases of epidemic potential. The company was founded in 1997 and headquartered in Rockville, Maryland.
Total Funding Amount:
$48.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Rockville, Maryland, United States
Founded Date:
1997-01-01
Contact Email:
mail(AT)sequella.com
Founders:
Carol Nacy, Leo Einck
Number of Employees:
11-50
Last Funding Date:
2016-09-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai